Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EJ
- Chemical substanceL01EJ02Fedratinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 1 registration
European Union
EMA · 1 registration
Croatia
HALMED · 1 registration
Netherlands
CBG-MEB · 1 registration
Singapore
HSA · 1 registration
At a glance
- ATC code
- L01EJ02
- Registers
- 6
- Registrations
- 6
- With their own page
- 6
- Companies
- 4
All medicines with Fedratinib
Human medicines from every register that match Fedratinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
7 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Inrebic | United States | 100MG BASE | capsule | Marketed | Bristol-Myers |
| Inrebic | European Union | Authorised | Bristol Myers Squibb Pharma EEIG | ||
| Inrebic 100 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Bristol-Myers Squibb Pharma EEIG | |
| Inrebic | Canada | 100 MG | Capsule | Marketed | Bristol-Myers Squibb Canada |
| Inrebic Capsules 100 MG | Singapore | 100 mg | capsule | Authorised | Bristol-Myers Squibb (Singapore) Pte. LTD. |
| Inrebic | Croatia | Marketed | |||
| INREBIC 100 mg CAPSULAS DURAS | Spain | 117,3 mg | cápsula dura | Marketed | Bristol-Myers Squibb Pharma Eeig |